Search Results
Found 1 results
510(k) Data Aggregation
(154 days)
ACTICHROME HEPARIN (ANTI-FXA), MODEL 832
ACTICHROME® Heparin (anti-fXa) is a chromogenic assay intended for the quantitative determination of unfractionated and low molecular weight heparins in human plasma. The assay measures the inhibition of factor Xa (fXa) activity by the various heparins. The Electra 900C® was used to determine performance data. This kit is for in vitro diagnostic use.
ACTICHROME® Heparin (anti-fXa) is a chromogenic assay intended for the quantitative determination of unfractionated and low molecular weight heparins in human plasma. The assay measures the inhibition of factor Xa (fXa) activity by the various heparins.
Here's an analysis of the provided text regarding the acceptance criteria and study for the ACTICHROME® Heparin (anti-fXa) device:
1. Table of Acceptance Criteria and Reported Device Performance
The provided text does not explicitly state pre-defined acceptance criteria (e.g., "The device must achieve an R-value of at least X"). Instead, it presents performance data and implies that equivalence to the predicate device is the overarching acceptance criterion. Thus, the "acceptance criteria" are inferred from the demonstrated performance in comparison to the predicate.
Acceptance Criteria (Inferred from Predicate Equivalence) | Reported Device Performance (ACTICHROME Heparin (anti-fXa)) |
---|---|
Method Comparison vs. Predicate Device | |
Positive correlation with predicate device (implied R > 0.8) | Unfractionated Heparin (Lot 007): R = 0.913, Y = 0.843X + 0.003, Sy.x = 0.07 |
Unfractionated Heparin (Lot 010): R = 0.859, Y = 0.765X - 0.009, Sy.x = 0.08 | |
LMW Heparin (Lot 010): R = 0.895, Y = 1.363X - 0.139, Sy.x = 0.14 | |
Precision (Intra-Assay CV%) | |
Maintain low intra-assay variability (implied |
Ask a specific question about this device
Page 1 of 1